This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
HCA Healthcare (HCA) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
HCA Healthcare (HCA) closed at $179.82 in the latest trading session, marking a -1.38% move from the prior day.
McKesson's (MCK) Latest JV to Boost Cancer Treatment Options
by Zacks Equity Research
McKesson's (MCK) latest activities in the oncology care space is expected to serve a wider patient pool.
HCA Healthcare (HCA) Scraps Utah Buyout Post FTC's Roadblock
by Zacks Equity Research
HCA Healthcare's (HCA) aborted acquisition follows another abandoned buyout plan involving RWJBarnabas Health and Saint Peter's Healthcare System.
HCA Healthcare (HCA) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
HCA Healthcare (HCA) closed the most recent trading day at $173.10, moving +0.9% from the previous trading session.
HCA Healthcare (HCA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, HCA Healthcare (HCA) closed at $181.69, marking a +1.34% move from the previous day.
Select Medical (SEM) Inks JV to Serve Venice and Nearby Areas
by Zacks Equity Research
Select Medical (SEM) teams up with Community Health's arm, ShorePoint Health Venice, for jointly operating a hospital dedicated to serve post-acute care needs of patients.
HCA Healthcare's (HCA) Galen College Adds 8th New Facility
by Zacks Equity Research
HCA Healthcare's (HCA) Galen College nursing campus addition comes when the country is suffering from a nursing shortage.
HCA Healthcare (HCA) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, HCA Healthcare (HCA) closed at $207.52, marking a +1.32% move from the previous day.
HCA Healthcare's (HCA) Utah Acquisition Faces Fed Roadblocks
by Zacks Equity Research
The trade watchdog expects HCA Healthcare's (HCA) Utah acquisition to induce market concentration and eliminate Steward Health Care as a low-cost competitor.
HCA Healthcare (HCA) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
HCA Healthcare (HCA) closed the most recent trading day at $206.95, moving -1.64% from the previous trading session.
HCA Healthcare (HCA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
HCA Healthcare (HCA) closed the most recent trading day at $206.16, moving +0.68% from the previous trading session.
Encompass Health (EHC) Unveils Plan to Better Serve Texas
by Zacks Equity Research
Encompass Health (EHC) announces plans to construct a 60-bed inpatient rehabilitation hospital in Texas in a bid to more effectively cater to the health issues of the state.
Zacks Earnings Trends Highlights: Netflix, General Electric, and HCA Holdings
by Zacks Equity Research
Netflix, General Electric, and HCA Holdings are part of Zacks Earnings Trends article.
Breaking Down the First Quarter Earnings Season So Far
by Sheraz Mian
Excluding the -16.3% decline in Finance sector earnings, Q1 earnings for the rest of the index members that have reported would be up +15.4%.
Breaking Down the First Quarter Earnings Season So Far
by Sheraz Mian
Excluding the -16.3% decline in Finance sector earnings, Q1 earnings for the rest of the index members that have reported would be up +15.4%.
Zacks Earnings Trends Highlights: Netflix, General Electric and HCA Holdings
by Zacks Equity Research
Netflix, General Electric and HCA Holdings have been highlighted in this Earnings Trends article.
Earnings Estimates Come Under Pressure Outside of Energy
by Sheraz Mian
Looking at Q1 as a whole, total S&P 500 earnings are expected to be up +6.6% on +11.1% higher revenues. This is a significant deceleration from what we have been seeing in the preceding quarters...
Earnings Estimates Come Under Pressure Outside of Energy
by Sheraz Mian
Looking at Q1 as a whole, total S&P 500 earnings are expected to be up +6.6% on +11.1% higher revenues. This is a significant deceleration from what we have been seeing in the preceding quarters...
Company News for Apr 25, 2022
by Zacks Equity Research
Companies in The News Are: SLB,HCA,KMB,NEM
HCA Healthcare (HCA) Q1 Earnings Miss, Trims '22 EPS View
by Zacks Equity Research
HCA Healthcare's (HCA) first-quarter results reflect elevated expenses related to salaries and benefits, partly offset by an uptick in revenues driven by higher patient admissions.
HCA Healthcare (HCA) Q1 Earnings Miss Estimates
by Zacks Equity Research
HCA (HCA) delivered earnings and revenue surprises of -3.51% and 1.64%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
What to Expect Ahead of HCA Healthcare's (HCA) Q1 Earnings?
by Zacks Equity Research
HCA Healthcare's (HCA) Q1 earnings are likely to reflect gain from better admissions and a higher revenue stream.
HCA Healthcare (HCA) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
HCA (HCA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Top Stock Reports for Pfizer, Charles Schwab & Vale
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Pfizer Inc. (PFE), The Charles Schwab Corporation (SCHW), and Vale S.A. (VALE).
Encompass Health (EHC) Relocates North Alabama Hospital
by Zacks Equity Research
Encompass Health (EHC) commences operations in its North Alabama hospital, which has been relocated with added capacity for better serving residents of the Huntsville community.